Abstract:Abstract Electrocatalysis has emerged as an increasingly viable platform for molecular syntheses, that can replace chemical redox agents and enable unprecedented reaction pathways. Despite major progress in electrooxidative C−H activations, these arene transformations generally require directing groups for chelation-induced efficiency and control of position-selectivity in the C−H activation. The installation and removal of these directing groups calls for additional synthesis operations, which jeopardizes the inherent efficacy of the C−H activation approach in terms of undesired waste formation and low resource economy. In sharp contrast, we herein present molecular electrocatalyzed C−H olefinations of simple arenes devoid of exogenous directing groups. The robust palladaelectro-catalysis proved amenable to a wide range of both electronically-diverse arenes under exceedingly mild reaction conditions. The strategy avoids sacrificial chemical oxidants, but operates by the reductive hydrogen evolution reaction (HER). This study points to a remarkable strategy comprising two electrochemical transformations to guarantee unprecedented levels of position-selectivities in direct arene olefinations. Cyclic voltammetry studies and computational analysis identified a direct correlation between the redox potential and catalysis efficacy. The palladaelectro-catalysis strategy avoids protecting and directing group interconversions, the practical importance of which is reflected by direct late-stage functionalizations of structurally complex compounds of relevance to drug discovery and pharmaceutical industries.

Late-stage peptide C–H alkylation for bioorthogonal C–H activation featuring solid phase peptide synthesis

Late-stage C(sp2)-H and C(sp3)-H Glycosylation Ofc-Aryl/alkyl Glycopeptides: Mechanistic Insights and Fluorescence Labeling

Late-stage meta-C–H alkylation of pharmaceuticals to modulate biological properties and expedite molecular optimisation in a single step

P III ‐directed Late‐Stage Ligation and Macrocyclization of Peptides with Olefins by Rhodium Catalysis

Late-Stage, Stereoretentive, and Site-Selective Modification of Synthetic Peptides by Using Photoredox Catalysis

Late-Stage Functionalization and Diversification of Peptides by Internal Thiazole-Enabled Palladium-Catalyzed C(sp3)–H Arylation

Remote C−H Glycosylation by Ruthenium(II) Catalysis: Modular Assembly Ofmeta‐c‐aryl Glycosides

Peptide Late-Stage Diversifications by Rhodium-Catalyzed Tryptophan C7 Amidation

Trinuclear gold-catalyzed site-selective alkylation of peptides

Late-stage Diversification by Rutheniumelectro-Catalyzed C–H Mono- and Di-Acyloxylation

Electrocatalyzed Direct Arene Alkenylations without Directing Groups: Selective Late-Stage Drug Diversification

Late‐Stage Peptide Macrocyclization by Palladium‐Catalyzed Site‐Selective C−H Olefination of Tryptophan

Nickel-Catalyzed Atroposelective C-H Alkylation Enabled by Bimetallic Catalysis with Air-Stable Heteroatom-Substituted Secondary Phosphine Oxide Preligands

Ruthenium(II)‐Catalyzed Pyridyl‐Directed Tryptophan C‐H Acylmethylation with α‐Chloro Ketones

Sustainable Ruthenium(II)-Catalyzed C–H Activations in and on H<sub>2</sub>O

Transition-metal-catalyzed CH Functionalization for Late-Stage Modification of Peptides and Proteins

Ruthenium(II)/Imidazolidine Carboxylic Acid‐Catalyzed C−H Alkylation for Central and Axial Double Enantio‐Induction

Late-Stage Modification of Peptides with Maleimides through Palladium-Catalyzed β-C(sp 3 )-H Alkylation

Enzymatic Late‐Stage Halogenation of Peptides

Programmable late-stage C−H bond functionalization enabled by integration of enzymes with chemocatalysis

Peptide-guided Functionalization and Macrocyclization of Bioactive Peptidosulfonamides by Pd(II)-catalyzed Late-Stage C–H Activation